2. Compass Pathways $33M
Funding Details: Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression. Founded in 2016, Compass Pathways has now raised a total of $37.94M in equity funding over two rounds.
Industry: Health Care, Life Science, Personal Health